A nationwide analysis of pancreatic cancer trial enrollment reveals disparities and participation problems

Our research group recently surveyed the clinical trial landscape in pancreatic adenocarcinoma and identified 430 active trials. These represent an opportunity to expand treatment options for patients with pancreatic adenocarcinoma. Our primary objective was to detail clinical trial participation among patients with pancreatic adenocarcinoma. Our secondary objective was to evaluate survival.

Source: Surgery - November 26, 2021 Category: Surgery Authors: Jonathan J. Hue, Erryk S. Katayama, Sarah C. Markt, Mohamedraed Elshami, Joel Saltzman, David Bajor, Amy Hosmer, Shaffer Mok, John Dumot, John B. Ammori, Luke D. Rothermel, Jeffrey M. Hardacre, Jordan M. Winter, Lee M. Ocuin Source Type: research